Swiss perspectives in 10 languages

Slovenia’s role in the global pharmaceutical supply chain

Switzerland’s becoming increasingly dependent on Slovenia’s pharmaceutical industries. For decades, Novartis and Sandoz have been investing large sums of money into the Balkan nation, turning into a key partner for development and manufacturing of both innovative and copycat drugs.

More
Novartis

More

Swiss pharma’s big bet on Slovenia

This content was published on As Swiss companies Novartis and Sandoz shift to complex, expensive medicine, they are increasingly dependent on the tiny Balkan nation of Slovenia.

Read more: Swiss pharma’s big bet on Slovenia

Edited by Nerys Avery and Marius Grieder.

External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
This month’s video picks

Never miss a new video in your language from SWI swissinfo.ch again; sign up to have them sent once a month straight to your inbox

Monthly

The SBC Privacy Policy provides additional information on how your data is processed.

You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR